SIMS TRIAL FOLLOW UP STUDY (FOLLOW UP TO RG11505):ADJUSTABLE ANCHORED SINGLE-INCISION MINI SLINGS VERSUS STANDARD TENSION FREE MIDURETHRAL SLINGS IN THE SURGICAL MANAGEMENT OF FEMALE STRESS URINARY INCONTINENCE: A PRAGMATIC MULTICENTRE NON-INFERIORITY RANDOMISED CONTROLLED TRIAL

Project: Contract

Project Details

Project Name

Long-Term Outcomes Of Synthetic Mid-Urethral Slings (Mesh Tapes) In Surgical Treatment Of Stress Urinary Incontinence In Women - A Long-term Follow-Up Of The SIMS RCT

Description / Abstract

Urinary incontinence in women is a major issue for the NHS and for society, with the number affected and cost of treatment posing a significant burden on healthcare. Stress Urinary Incontinence (SUI) is the involuntary loss of urine through exercise, laughing, etc. It is the most common form of incontinence in premenopausal women and can have a significant negative effect on women's quality of life. Non-surgical treatments seek to increase the support of the urethra with pelvic floor exercises but if these fail then surgery is the only alternative. In the most common surgical procedure, standard mid urethral slings (SMUS or mesh tape), a long strip of polypropylene mesh/ tape is placed under the urethra to provide support. An alternative procedure, single-incision mini-sling (SIMS) is almost 50% less mesh volume and designed to have advantages over SMUS. A pilot study has shown SIMS to have fewer operative complications; less pain during and after the procedure; can be done under local anaesthesia; with earlier recovery of participants; shorter hospital stay; earlier return to normal activities and/or work. Economic analysis has also shown potential economic benefit to the NHS resources and wider society. In the HTA-funded SIMS study 600 women, aged over 18 years, from 21 hospitals in the UK randomly received either a SIMS or SMUS procedure. The progress of these women has been followed up over 3 years, post operatively, measuring potential benefits, risks and costs associated with each procedure and will be reported fully in early 2021. It will help inform decision making for patients with SUI, their surgeons and the relevant policy makers with regards the most clinically and cost-effective procedure for women with SUI. We now propose to further follow-up these women (SIMS cohort) up-to 10 years following their operation. The aim of the SIMS long-term follow-up (up to 10 years) is three-fold. Firstly, to provide women, clinicians and policy makers with further clinical and economic information to aid decision making. The embedded qualitative study will explore women's voices about the decision-making process to undergo SUI surgery. Secondly, to provide detailed long-term safety information on mesh based SUI surgical procedures. Thirdly, the duration of this long-term follow-up (10 years) will provide new information on the landscape of any late-onset adverse events and associated surgical procedures. We have consulted with women and the public to decide the optimum length of the long-term follow-up. Our team is the same expert team that delivered the initial SIMS study and further enhanced with two expert clinicians and two patients/ public representatives. We will send yearly questionnaires to the SIMS participants. We will ask about their urinary symptoms and how they affect their quality of life and any treatments they have received since the SIMS study operation. We will use the same follow-up tools and process that we used in the initial SIMS study and have proven successful in keeping the study participants well engaged with the study (87% and 81% response rates at 1 & 3 years respectively). We will collect information on further treatments for continence or adverse events from medical records and routine data sources. We will ask participants to take part in an interview about their experiences of treatment, the impact on their life, and what they think with hind sight about the treatment decisions they made.
StatusActive
Effective start/end date1/06/2131/03/28